Osaic Holdings
SRNE

Osaic Holdings’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Osaic Holdings’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-105,484
Closed -$92.9K – 7671
2022
Q4 		$92.9K Sell
105,484
-14,585
-12% -$19.3K ﹤0.01% 4500
2022
Q3 		$190K Sell
120,069
-3,195
-3% -$7.25K ﹤0.01% 3789
2022
Q2 		$250K Sell
123,264
-7,138
-5% -$12.3K ﹤0.01% 3572
2022
Q1 		$3.98M Sell
130,402
-23,284
-15% -$72.6K 0.01% 1369
2021
Q4 		$718K Sell
153,686
-31,140
-17% -$193K ﹤0.01% 2712
2021
Q3 		$1.4M Sell
184,826
-151
-0.1% -$1.28K ﹤0.01% 2039
2021
Q2 		$1.8M Sell
184,977
-47,223
-20% -$376K ﹤0.01% 1814
2021
Q1 		$1.92M Buy
232,200
+25,952
+13% +$274K ﹤0.01% 1660
2020
Q4 		$1.41M Buy
206,248
+4,969
+2% +$39.9K ﹤0.01% 1747
2020
Q3 		$2.21M Buy
201,279
+86,654
+76% +$793K 0.01% 1246
2020
Q2 		$721K Buy
114,625
+103,900
+969% +$398K ﹤0.01% 2024
2020
Q1 		$21K Buy
+10,725
New +$30.9K ﹤0.01% 4624

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Osaic Holdings's SRNE Position: Q1 2023 in Review

Osaic Holdings sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 105,484 shares — an estimated $92.9K sold.

Osaic Holdings first reported a position in SRNE in Q1 2020 and held it in 12 quarters. The position peaked at $3.98M in Q1 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Osaic Holdings reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 105,484 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $92.9K.
  • Osaic Holdings first reported a position in Sorrento Therapeutics, Inc. in Q1 2020 and held it in 12 quarters.
  • Osaic Holdings's Sorrento Therapeutics, Inc. position peaked at $3.98M in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.